Disclosure of Conflicts of Interest:
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. The existence or absence of COI for everyone in a position to control educational content will be disclosed to participants prior to the start of each activity.
|Beth Faiman has disclosed that she received consulting fees from Janssen, Pfizer, and Sanofi.|
|Amy E. Pierre
MSN, RN, ANP-BC
|Amy E. Pierre has disclosed that she received speaking honoraria from BMS, consulting fees from Pfizer, and owns stock in Roche. Ms. Pierre is employed by Flatiron Health.|
MSN, NP-C, AOCNP®
|Charise Gleason has disclosed that she received consulting fees from Pfizer and GSK.|
PhD, ANP-BC, AOCNP®
|Tiffany Richards has disclosed that she received consulting fees from BMS, Janssen, and GSK.|
The staff reported the following relevant financial relationships they have with ineligible companies related to the content of this activity:
RN, MA, EdM
|Diane Moran has no relevant financial relationships to report.|
|Michelle Faber has no relevant financial relationships to report.|
|Joyce Divine has no relevant financial relationships to report.|
All of the relevant financial relationships listed for these individuals have been mitigated.